Cognition Therapeutics Files Routine 8-K on Jan 4, 2024

Ticker: CGTX · Form: 8-K · Filed: Jan 4, 2024 · CIK: 1455365

Cognition Therapeutics INC 8-K Filing Summary
FieldDetail
CompanyCognition Therapeutics INC (CGTX)
Form Type8-K
Filed DateJan 4, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: corporate-filing, other-events, routine-disclosure

TL;DR

**Cognition Therapeutics filed a routine 8-K, no major news.**

AI Summary

Cognition Therapeutics, Inc. filed an 8-K on January 4, 2024, to report 'Other Events' and 'Financial Statements and Exhibits.' This filing is a routine update, indicating no major new developments but rather a standard disclosure of general corporate information. For investors, this means there are no immediate red flags or significant positive catalysts revealed in this particular filing, suggesting a neutral impact on the stock based solely on this document.

Why It Matters

This filing is a standard disclosure, indicating no immediate material changes or events that would significantly impact the company's operations or stock price. It's a procedural update rather than a substantive one.

Risk Assessment

Risk Level: low — This 8-K is a general corporate filing with no specific financial or operational disclosures that would introduce new risks.

Analyst Insight

Given this is a routine 8-K with no specific material disclosures, a smart investor would not make any immediate trading decisions based solely on this filing. Instead, they would continue to monitor for more substantive news, such as clinical trial results, financing rounds, or earnings reports.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by Cognition Therapeutics, Inc.?

This 8-K filing by Cognition Therapeutics, Inc. is a 'Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' and specifically reports 'Other Events' and 'Financial Statements and Exhibits' as of January 4, 2024.

When was the earliest event reported in this 8-K filing?

The date of the earliest event reported in this 8-K filing is January 4, 2024.

What is the state of incorporation for Cognition Therapeutics, Inc.?

Cognition Therapeutics, Inc. is incorporated in Delaware, as stated in the filing.

What is the business address listed for Cognition Therapeutics, Inc. in this filing?

The business address for Cognition Therapeutics, Inc. is 2500 Westchester Ave., Purchase, NY 10577, with a telephone number of (412) 481-2210.

Does this 8-K filing indicate any specific new financial or operational developments for Cognition Therapeutics, Inc.?

No, this 8-K filing is categorized under 'Other Events' and 'Financial Statements and Exhibits' but does not detail any specific new financial or operational developments beyond general corporate information. It appears to be a routine filing.

Filing Stats: 428 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-01-04 16:21:33

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. Attached as Exhibit 99.1 is a presentation that the Company may use from time to time in presentations or discussions with investors, analysts, and other parties.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Document 99.1 Investor presentation of Cognition Therapeutics, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COGNITION THERAPEUTICS, INC. Date: J anuary 4 , 2024 By: /s/ Lisa Ricciardi Name: Lisa Ricciardi Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing